# It is Possible to Maintain the Performance of Screening Colonoscopies Under MEOPA During the Covid 19 Epidemic Period When Access to the Operating Room is Limited

> **NCT05336617** · — · COMPLETED · sponsor: **Centre Hospitalier Sud Francilien** · enrollment: 282 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **PROCEDURE:** colonoscopy

## Key facts

- **NCT ID:** NCT05336617
- **Lead sponsor:** Centre Hospitalier Sud Francilien
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-13
- **Primary completion:** 2022-06-13
- **Final completion:** 2022-06-13
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2022-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05336617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05336617, "It is Possible to Maintain the Performance of Screening Colonoscopies Under MEOPA During the Covid 19 Epidemic Period When Access to the Operating Room is Limited". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05336617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*